TITLE

P-0094 HEPATIC ARTERIAL INFUSION OF CHEMOTHERAPY AS A SALVAGE THERAPY FOR PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

AUTHOR(S)
Yu-Yun, Shao; Po-Chin, Liang; Yao-Ming, Wu; Chun-Chieh, Huang; Kai-Wen, Huang; Chia-Hsien, Cheng Jason; Chih-Hung, Hsu; Chiun, Hsu; Ann-Lii, Cheng; Zhong-Zhe, Lin
PUB. DATE
June 2014
SOURCE
Annals of Oncology;Jun2014, Vol. 25 Issue suppl_2, pii42
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
96731277

 

Related Articles

  • Fluorouracil.  // Reactions Weekly;5/26/2012, Issue 1403, p17 

    The article describes the cases of two patients who developed either hepatic artery stenosis or biloma with hepatic artery stenosis while receiving fluorouracil for their pancreatic head cancer.

  • Salvage therapy with single agent bendamustine for recurrent glioblastoma. Chamberlain, Marc; Johnston, Sandra // Journal of Neuro-Oncology;Dec2011, Vol. 105 Issue 3, p523 

    The treatment of recurrent glioblastoma (GBM) remains challenging notwithstanding the recent approval of bevacizumab for this indication. Bendamustine has a bifunctional mechanism of action including alkylation, penetrates the CNS and does not show cross resistance to other alkylator...

  • A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma. Song, Myeong; Bae, Si; Chun, Ho; Choi, Jong; Yoon, Seung; Park, Jun; Han, Kwang; Kim, Young; Yim, Hyung; Um, Soon; Chung, Woo; Hwang, Jae; Cho, Sung-Bum; Eun, Jong // Cancer Chemotherapy & Pharmacology;Apr2015, Vol. 75 Issue 4, p739 

    Purpose: This multicenter, randomized, open-labeled, clinical trial evaluated the efficacy and safety of cisplatin/5-fluorouracil (5-FU) hepatic arterial infusion chemotherapy (CF-HAIC) versus adriamycin adding to CF-HAIC (ACF-HAIC) in advanced HCC patients. Methods: Fifty-six patients with...

  • Current chemotherapeutic approaches for hepatoblastoma. Watanabe, Kenichiro // International Journal of Clinical Oncology;Dec2013, Vol. 18 Issue 6, p955 

    Cisplatin-based chemotherapy has markedly improved the survival of patients with standard-risk hepatoblastoma (HB). However, treatment results for patients with metastatic disease remain unsatisfactory. As a result, the current therapeutic strategy for HB is to decrease dose intensity for...

  • Evaluation of the progression and treatment of experimental periodontitis in rats subjected to chemotherapy with 5-fluorouracil. Garcia, Valdir; Novaes, Vivian; Almeida, Juliano; Longo, Mariéllen; Ervolino, Edilson; Bomfim, Suely; Theodoro, Leticia // Supportive Care in Cancer;Jul2015, Vol. 23 Issue 7, p2007 

    Aim: This study aimed to evaluate the progression and treatment of experimental periodontitis (EP) in rats treated with 5-fluorouracil (5-FU). Materials and methods: One-hundred fifty rats were divided into groups: C-control, EP-EP induction, EP/scaling and root planing (SRP)-EP induction and...

  • Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancer. FAURE, MARJORIE; NICCOLI, PATRICIA; AUTRET, AURELIE; CAVAGLIONE, GERARD; MINEUR, LAURENT; RAOUL, JEAN-LUC // Molecular & Clinical Oncology;2017, Vol. 6 Issue 1, p44 

    Neuroendocrine tumors (NETs) comprise a heterogeneous group of malignancies with various clinical presentations and evolution. NETs are often diagnosed at a late stage, when they are already metastatic. Treatment is currently based on traditional chemotherapies, such as streptozocin, with...

  • Case report of very late gastric cancer recurrence. Blanchette, P.; Lipton, J. H.; Barth, D.; Mackay, H. // Current Oncology;Apr2013, Vol. 20 Issue 2, pe161 

    Very late recurrence of gastric cancer is rare. Here, we report a dramatic recurrence of gastric cancer, with isolated skeletal metastasis and bone marrow carcinomatosis, 22 years after the patient's initial presentation. Gastric cancer recurrence involving bone or bone marrow is also uncommon...

  • “I Had Cancer… and It Changed Everything”. PAI, DEANNA // Cosmopolitan;Feb2016, Vol. 260 Issue 2, p104 

    A personal narrative is presented in which the author shares her experience of living life after six rounds of chemotherapy, two surgeries, three transfusions and one stay in isolation due to a rare liver cancer.

  • Dihydropyrimidine dehydrogenase pharmacogenetics in the Taiwanese population. Hsiao, Hui-Hua; Yang, Ming-Yu; Chang, Jan-Gowth; Liu, Yi-Chang; Liu, Ta-Chih; Chang, Chao-Sung; Chen, Tyen-Po; Lin, Sheng-Fung // Cancer Chemotherapy & Pharmacology;May2004, Vol. 53 Issue 5, p445 

    Background/purpose. 5-Fluorouracil (5-FU) remains the most frequently used chemotherapy agent in various human cancers. Over 80% of the 5-FU administered is metabolized by dihydropyrimidine dehydrogenase (DPD) in the liver. However, mutations in the DPD gene have been found to be associated with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics